Varicose Veins Treatment Market Report 2026

Varicose Veins Treatment Market Overview

• Varicose Veins Treatment market size has reached to $2.11 billion in 2025 • Expected to grow to $2.85 billion in 2030 at a compound annual growth rate (CAGR) of 6.1% • Growth Driver: Increasing Demand For Minimally Invasive Procedures Fuels Market Growth • Market Trend: Advancements In Minimally Invasive Vein Procedures • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Varicose Veins Treatment Market?

Varicose vein treatment refers to medical procedures and interventions designed to alleviate symptoms, improve blood circulation, and prevent complications caused by swollen, twisted veins, primarily in the legs. It also addresses cosmetic concerns by enhancing the appearance of affected veins while reducing the risk of associated issues such as pain, ulcers, or blood clots. The main products in varicose veins treatment are ablation devices, radiofrequency ablation devices, and laser ablation devices. Ablation devices refer to medical tools used to remove or destroy abnormal tissue, such as tumors or varicose veins, through methods such as heat, cold, or electrical energy. The procedures include injection sclerotherapy, endovenous ablation, and surgical ligation or stripping. End-users of these treatments include hospitals, specialized clinics, ambulatory surgical centers, and other healthcare providers.

What Is The Varicose Veins Treatment Market Growth Forecast?

The varicose veins treatment market size is expected to see strong growth in the next few years. It will grow to $2.85 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing aging population, rising adoption of non-surgical treatments, growing investments in vascular care infrastructure, expansion of ambulatory surgical centers, increasing focus on early diagnosis and intervention. Major trends in the forecast period include increasing adoption of minimally invasive treatment procedures, rising demand for laser-based ablation techniques, growing preference for outpatient treatment settings, expansion of cosmetic vein treatment solutions, enhanced focus on patient recovery and comfort.

Global Varicose Veins Treatment Market Segmentation

1) By Product: Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices 2) By Procedure: Injection Sclerotherapy, Endovenous Ablation, Surgical Ligation Or Stripping 3) By End-User: Hospitals, Specialized Clinics, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Ablation Devices: Endovenous Laser Therapy (EVLT) Devices, Sclerotherapy Devices 2) By Radiofrequency Ablation Devices: Radiofrequency Catheters, RF Ablation Systems 3) By Laser Ablation Devices: Laser Fiber Optic Devices, Laser Venous Ablation Systems

What Is The Driver Of The Varicose Veins Treatment Market?

Increasing demand for minimally invasive procedures is expected to propel the growth of the varicose veins treatment market going forward. Minimally invasive procedures are surgical techniques that utilize small incisions and specialized instruments to perform operations with less tissue damage, resulting in reduced pain, shorter recovery times, and minimal scarring compared to traditional open surgery. The increasing demand for minimally invasive procedures is driven by factors such as reduced recovery time, improved patient outcomes, and the growing aging population, which collectively enhance patient safety, satisfaction, and efficiency in healthcare. Minimally invasive procedures for varicose veins, such as endovenous laser therapy (EVLT) or sclerotherapy, effectively treat the condition with minimal discomfort, quicker recovery, and fewer complications. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US based nonprofit professional association, nearly 25.4 million cosmetic minimally invasive procedures were performed in 2023, representing a 7 percent increase compared to the previous year. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the varicose veins treatment industry.

Key Players In The Global Varicose Veins Treatment Market

Major companies operating in the varicose veins treatment market are Medtronic PLC, Becton Dickinson and Company, Boston Scientific Corporation, BTG Limited, Merit Medical Systems Incorporated, AngioDynamics Incorporated, Medi USA Limited Partnership, Dornier MedTech GmbH, Sciton Incorporated, Invera Medical Limited, Biolitec AG, Alma Lasers Limited, Won Tech Company Limited, F Care Systems S.A., Vascular Solutions Incorporated, Theraclion S.A., Lumenis Ltd, Syneron Medical Ltd, Quanta System S.p.A, Energist Group, LSO Medical

Global Varicose Veins Treatment Market Trends and Insights

Major companies operating in the varicose veins treatment market are focused on developing innovative solutions such as anesthesia-free treatment to enhance patient outcomes, streamline treatment monitoring, improve accessibility to care, and provide personalized therapeutic approaches. Anesthesia-free treatment involves performing medical procedures without the use of anesthesia, offering improved safety, quicker recovery, and greater patient comfort. For instance, in April 2024, VVT MEDICAL Ltd., an Israel-based medical device company, received approval from South Korea's Ministry of Food and Drug Safety for its ScleroSafe platform, a cutting-edge solution for minimally invasive varicose vein treatment. This platform utilizes a nonthermal, nontumescent (NT-NT) approach, eliminating the need for heat or tumescent anesthesia, ensuring a painless, anesthesia-free procedure. Designed for both medical and aesthetic purposes, it prioritizes patient comfort and efficacy. The platform has received several regulatory approvals, including CE Mark certification and FDA 510(k) clearance, and complies with Good Manufacturing Practices (GMP), positioning ScleroSafe as a groundbreaking innovation in varicose vein management.

What Are Latest Mergers And Acquisitions In The Varicose Veins Treatment Market?

In January 2024, VVT MEDICAL Ltd., an Israel-based medical device company, partnered with Methapharm Inc. to treat varicose veins using a dual syringe technique. This collaboration allows VVT Medical to strengthen its presence in the U.S. market by leveraging Methapharm's expertise in promoting and distributing the ScleroSafe platform for varicose vein treatment. Methapharm Inc. is a Canada-based pharmaceutical company that specializes in varicose vein treatment.

Regional Outlook

North America was the largest region in the varicose veins treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Varicose Veins Treatment Market?

The varicose veins treatment market consists of revenues earned by entities providing services such as diagnostic services, minimally invasive treatments, and surgical services. The market value includes the value of related goods sold by the service provider or included within the service offering. The varicose veins treatment market also includes sales of laser treatment devices, sclerotherapy agents, and radiofrequency ablation devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Varicose Veins Treatment Market Report 2026?

The varicose veins treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the varicose veins treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.